9.2 Acquisition Date & Consideration Transferred

9.2 Acquisition Date & Consideration Transferred

Core Principle: Purchase consideration in a business combination must be measured at acquisition-date fair value. The acquisition date represents the exact point in time when control passes to the acquirer, establishing the measurement baseline for all assets acquired, liabilities assumed, and consideration transferred.

Accurately establishing the acquisition date and measuring the consideration transferred are critical steps in applying the acquisition method. Because asset values, foreign exchange rates, and public equity prices fluctuate continuously, fixing the precise moment of control and properly valuing all consideration components directly determines the resulting goodwill or bargain purchase gain.

---

Determining the Acquisition Date

Under IFRS 3.8–9, the acquisition date is defined as:

The date on which the acquirer obtains control of the acquiree.

Closing Date vs Agreement Date

The acquisition date is generally the closing date (also termed the completion date)—the date on which the acquirer legally transfers the consideration, acquires the assets, and assumes the liabilities of the acquiree.

Candidates must distinguish the acquisition date from earlier milestones:

• The Agreement Date: The date on which a binding contract or merger agreement is executed between the parties. Agreement dates often precede closing by months while regulatory, shareholder, or financing conditions are satisfied.
• The Announcement Date: The date the proposed combination is publicly disclosed to the market.
• The Regulatory Approval Date: The date competition or antitrust regulators (such as the ACCC in Australia) issue clearance.

Transfer of Control Prior to Legal Closing

While the closing date provides the default legal presumption, IFRS 3.9 recognizes that an acquirer might obtain control on a date that is earlier or later than the closing date if a written agreement specifies that control transfers ahead of legal completion. For example, if the agreement provides that the acquirer assumes board control, operational direction, and the risks and rewards of economic ownership on 1 October, while statutory share registry transfer and final cash settlement occur on 1 December, the acquisition date is 1 October.

Consolidation begins strictly from the acquisition date: the acquiree's operating revenues and expenses prior to the acquisition date are excluded from the consolidated statement of profit or loss.

---

Components of Consideration Transferred

Under IFRS 3.37, the consideration transferred in a business combination is measured at acquisition-date fair value (calculated in accordance with IFRS 13 Fair Value Measurement). It is computed as the sum of:

$$\text{Consideration Transferred} = \text{Cash} + \text{FV of Non-Cash Assets} + \text{Liabilities Incurred} + \text{FV of Equity Issued} + \text{FV of Contingent Consideration}$$

1. Cash and Cash Equivalents

Comprises immediate cash payments made to the former owners of the acquiree.

2. Fair Value of Non-Cash Assets Transferred

If the acquirer transfers non-cash assets (e.g., real estate, marketable investment portfolios, or plant equipment) to former owners as consideration:

• The assets are measured at acquisition-date fair value.
• If the carrying amount of the transferred asset differs from its fair value at the acquisition date, the acquirer must remeasure the asset to fair value and recognize the resulting gain or loss immediately in profit or loss.
• Exception: If the transferred non-cash assets remain within the combined group after the combination (e.g., transferred to a subsidiary), no remeasurement gain or loss is recognized.

3. Liabilities Incurred by the Acquirer

Includes obligations incurred by the acquirer to the former owners, such as deferred cash consideration:

• If cash consideration is payable at a future date (e.g., $50 million payable in two years), it must be discounted to its present value at the acquisition date using the acquirer's incremental borrowing rate for a comparable liability.
• The unwinding of the discount over the deferral period is recognized as a finance cost in profit or loss under IFRS 9; it is never added to goodwill.

4. Equity Interests Issued by the Acquirer

When the acquirer issues its own ordinary shares or options as consideration:

• The shares are measured at their acquisition-date market price (quoted closing bid/trade price on the acquisition date), not the market price on the agreement date or announcement date.
• If the shares are not publicly traded, their fair value must be estimated using professional valuation methodologies under IFRS 13.

Contingent Consideration Mechanics

Contingent consideration represents an obligation of the acquirer to transfer additional economic assets (cash, other assets, or equity securities) to former owners if specified future performance milestones or events occur (e.g., reaching a designated EBITDA target over three years, achieving regulatory drug approval, or hitting commercial production volumes).

Mandatory Initial Recognition

Under IFRS 3.39, the acquirer must recognize contingent consideration at acquisition-date fair value as part of the total consideration transferred.

Exam Trap: Under IAS 37, liabilities are recognized only if outflow is probable (>50%). In stark contrast, under IFRS 3, contingent consideration is always recognized at fair value, even if the likelihood of payment is low (e.g., 20%). The probability of occurrence is factored directly into the fair value calculation (e.g., using probability-weighted expected present value techniques).

Classification: Equity vs Financial Liability (IAS 32 Principles)

The instrument must be classified at initial recognition based on the substance of the contractual arrangement under IAS 32 Financial Instruments: Presentation:

1. Equity Classification: The contingent obligation qualifies as equity only if the acquirer is obligated to deliver a fixed number of its own equity instruments upon satisfaction of the condition ("fixed-for-fixed" rule).
2. Financial Liability Classification: If the contingent obligation requires the payment of cash, the delivery of other financial assets, or the issuance of a variable number of shares equal to a specified monetary amount, it must be classified as a financial liability.

Subsequent Accounting for Contingent Consideration

The subsequent accounting treatment depends entirely on this initial classification:

Treatment of Acquisition-Related Costs

In executing a corporate takeover, acquirers incur substantial transaction costs. IFRS 3 establishes strict, non-negotiable boundaries regarding their accounting classification:

                          Transaction Costs Incurred
                                      │
       ┌──────────────────────────────┼──────────────────────────────┐
       ▼                              ▼                              ▼
Professional Fees            Debt Issuance Costs            Equity Issuance Costs
(Advisory, Legal, Audit)     (Loan Establishment, Bonds)    (Share Underwriting, Prospectus)
       │                              │                              │
       ▼                              ▼                              ▼
Expense in P/L as Incurred   Deduct from Debt Liability     Deduct Directly from Equity
(IFRS 3.53 Mandate)          (IFRS 9 Amortised Cost)        (IAS 32.35 / Net of Tax)

1. General Acquisition-Related Costs (IFRS 3.53)

All costs incurred by the acquirer to effect a business combination—including finder's fees, advisory, legal, accounting, valuation, consulting, and general administrative expenses (including the overheads of an internal corporate development or M&A department)—must be expensed in profit or loss in the periods in which the costs are incurred and the services are received.

Rationale: Advisory fees do not represent economic resources controlled by the entity that will generate future cash inflows. Capitalizing advisory fees into goodwill was prohibited under the 2008 revision of IFRS 3 to prevent entities from artificially inflating intangible assets with transaction friction costs.

2. Debt Issuance Costs (IFRS 9)

If the acquirer raises debt financing (e.g., bank syndication fees, bond issue underwriting costs) to fund the acquisition:

• The costs are accounted for under IFRS 9 Financial Instruments.
• They are deducted from the initial carrying amount of the financial liability and amortized over the loan term using the effective interest method.

3. Equity Issuance Costs (IAS 32)

If the acquirer issues its own equity shares to fund the acquisition or as direct consideration:

• Costs directly attributable to the issue of new shares (e.g., share registry fees, underwriting fees, prospectus legal costs) are accounted for under IAS 32.35.
• They are recognized as a direct deduction from equity (debited to share capital or share premium), net of any related income tax benefit. They do not touch the profit or loss statement.

Worked Technical Scenario: Consideration Accounting & Subsequent Measurement

Scenario Details

On 1 July 2026, Meridian Corporation acquires 100% of the voting equity of Vantage Software Pty Ltd. The agreed consideration structure comprises:

1. Immediate Cash: $40 million paid at closing on 1 July 2026.
2. Deferred Cash Consideration: $24.2 million payable on 30 June 2028 (two years post-acquisition). Meridian's market borrowing rate for a two-year loan is 10.0% per annum.
3. Share Consideration: 5,000,000 ordinary shares of Meridian Corporation. On the agreement date (1 May 2026), Meridian shares were trading at $4.50. On the acquisition date (1 July 2026), Meridian shares closed at $5.20.
4. Contingent Consideration: Meridian agrees to pay $10 million cash on 30 June 2028 if Vantage achieves cumulative cloud revenues of $50 million. At 1 July 2026, the probability-weighted fair value of this contingent liability is assessed at $6.5 million.
5. Transaction Costs: Meridian pays $1.8 million in M&A advisory and legal due diligence fees, and $600,000 in investment banking underwriting fees directly related to the new share issuance.

Step 1: Calculate Acquisition-Date Consideration Transferred (1 July 2026)

$$\begin{aligned} \text{Immediate Cash} &= \$40,000,000 \\[4pt] \text{Deferred Cash Consideration (Present Value)} &= \frac{\$24,200,000}{(1 + 0.10)^2} = \frac{\$24,200,000}{1.21} = \$20,000,000 \\[4pt] \text{Share Consideration (Acquisition-Date Market Price)} &= 5,000,000 \text{ shares} \times \$5.20 = \$26,000,000 \\[4pt] \text{Contingent Consideration (Acquisition-Date Fair Value)} &= \$6,500,000 \\[4pt] \hline \textbf{Total Consideration Transferred} &= \textbf{\$92,500,000} \end{aligned}$$

Key Notes:

• The share consideration uses the acquisition-date price of $5.20, not the agreement-date price of $4.50.
• The $1.8M advisory fee is excluded from consideration and expensed immediately in P/L.
• The $600,000 equity underwriting fee is deducted directly from equity (share capital), reducing net share proceeds to $26.0M - $0.6M = $25.4M.

Step 2: Journal Entries on Acquisition Date (1 July 2026)

Dr  Investment in Vantage (Identifiable Net Assets & Goodwill)  $92,500,000
Dr  M&A Advisory Expense (Profit or Loss)                       $1,800,000
Dr  Share Capital / Equity (Share Issue Costs)                    $600,000
    Cr  Cash (Immediate Cash: $40M + Fees: $2.4M)                           $42,400,000
    Cr  Deferred Consideration Liability (Present Value)                     $20,000,000
    Cr  Contingent Consideration Liability (Fair Value)                       $6,500,000
    Cr  Share Capital (5,000,000 shares @ $5.20)                             $26,000,000

Step 3: Subsequent Accounting at 30 June 2027 (Year 1 Post-Acquisition)

At 30 June 2027, the following events occur:

1. Unwinding of Discount on Deferred Consideration:

$$\text{Finance Expense} = \$20,000,000 \times 10\% = \$2,000,000$$

Carrying value of deferred liability increases from $20M to $22M. 2. Remeasurement of Contingent Consideration: Due to exceptional customer adoption, the probability of meeting the revenue target increases, and the revised fair value of the contingent liability is determined to be $8.2 million.

$$\text{Fair Value Loss} = \$8.2\text{M} - \$6.5\text{M} = \$1,700,000 \quad (\text{recognized in P/L})$$

Dr  Finance Cost (Profit or Loss)                                $2,000,000
    Cr  Deferred Consideration Liability                                     $2,000,000

Dr  Contingent Consideration Fair Value Loss (Profit or Loss)    $1,700,000
    Cr  Contingent Consideration Liability                                   $1,700,000

Notice that neither adjustment alters the original goodwill recognized at 1 July 2026; both flows pass strictly through profit or loss.